Portfolio Services Ltd.'s Net Worth

$392 Million

Estimate Recalculated Feb 26, 2024 04:08PM EST

Who is Portfolio Services Ltd.?

Portfolio Services Ltd. has an estimated net worth of $392 Million. This is based on reported shares across multiple companies, which include AASTROM BIOSCIENCES INC, PEREGRINE PHARMACEUTICALS INC, Cyclacel Pharmaceuticals, Inc., iBio, Inc., Marker Therapeutics, Inc., and CYTOKINETICS INC.

SEC CIK

Portfolio Services Ltd.'s CIK is 0001488856

Past Insider Trading and Trends

2016 was Portfolio Services Ltd.'s most active year for acquiring shares with 6 total transactions. Portfolio Services Ltd.'s most active month to acquire stocks was the month of April. 2020 was Portfolio Services Ltd.'s most active year for disposing of shares, totalling 9 transactions. Portfolio Services Ltd.'s most active month to dispose stocks was the month of July. 2020 saw Portfolio Services Ltd. paying a total of $6,285,000.40 for 29,341,667 shares, this is the most they've acquired in one year. In 2020 Portfolio Services Ltd. cashed out on 29,592,160 shares for a total of $98,166,409.01, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AASTROM BIOSCIENCES INC (VCEL) Snapshot price: $44.0175

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+85.30%
362.5K
$4.80
$1,740,000.00
787.49K
Jul 9
Form 3
0
0
No matching records found

PEREGRINE PHARMACEUTICALS INC (CDMO) Snapshot price: $6.21

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Form 3
0
0
No matching records found

Cyclacel Pharmaceuticals, Inc. (CYCC) Snapshot price: $2.3718

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Form 4
+64.53%
850K
$2.00
$1,700,000.00
2.17M
Jul 19
Form 3
0
0
No matching records found

iBio, Inc. (IBIO) Snapshot price: $1.09

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+105.98%
4.44M
$1.74
-$74,160,683.17
8.63M
Aug 7 - Aug 11
Form 4
-11.42%
-4.27M
$4.27
-$18,220,725.85
33.11M
Aug 4 - Aug 6
Form 4
+35.16%
2.2M
$0.90
$1,980,000.00
8.46M
Jul 12
Form 4
+36.80%
1.68M
$0.90
$1,515,000.60
6.26M
Jun 26
Form 4
+35.56%
12M
$0.20
$2,400,000.00
45.74M
Nov 30
Form 4
+23.86%
6.5M
$0.62
$4,043,000.00
33.74M
Apr 7
Form 4
+24.06%
5.28M
$0.59
$3,122,520.00
27.24M
Jan 25
Form 4/A
+51.87%
7.5M
$0.40
$3,000,000.00
21.96M
Oct 15
Form 4
+44.60%
4.46M
14.46M
Apr 26
Form 3
0
0
No matching records found

Marker Therapeutics, Inc. (MRKR) Snapshot price: $4.1193

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Form 4
0
0
Jun 16
Form 4
+11.47%
416.67K
$1.20
$500,000.40
4.05M
Feb 18
Form 4
+32.50%
1.3M
$2.40
$3,120,000.00
5.3M
May 14
Form 4
+40.00%
8M
$0.50
28M
Aug 10
Form 4
+100.00%
10M
$0.20
$2,000,000.00
20M
Sep 9
Form 4
+100.00%
5M
$0.50
$2,500,000.00
10M
Jun 16
Form 4
0
0
May 28
Form 3
0
0
No matching records found